FDA Approvals

Date Posted
Article Title
7/27/2015
Praluent Approved to Treat High Cholesterol

For people at risk of heart attack or stroke

7/24/2015
Technivie Approved for Hepatitis C

For people with a genetic subtype of the liver infection

7/24/2015
7/24/2015
Test to Differentiate HIV Viruses Approved

Among people two years and older

7/16/2015
Novel Leg Prosthesis Approved

For people who can't use conventional device

7/13/2015
Iressa Approved for Specific Late-Stage Lung Cancer

New companion diagnostic can identify candidates

7/13/2015
Rexulti Approved for Schizophrenia, Depression

But shouldn't be prescribed to some older people

7/7/2015
Entresto Approved for Heart Failure

When heart can't pump enough blood

7/2/2015
Orkambi Approved for Cystic Fibrosis

When disease caused by mutated gene from each parent

6/22/2015
Anti-Clotting Drug Approved For Angioplasty

Kengreal prevents blood platelets from accumulating

6/17/2015
Improved Artificial Heart Valve Approved

Changes designed to minimize leaks

6/15/2015
Brain Stimulation Device Approved for Parkinson's and Essential Tremor

For use after medication alone proves inadequate

5/29/2015
Rapamune Approved for Rare Lung Disease

LAM affects mostly women of child-bearing age

5/28/2015
Two Drugs Approved for Irritable Bowel

Syndrome affects up to 15 percent of U.S. adults

5/11/2015
Spinal Stimulation System Relieves Pain Without Tingling

Implanted device treats chronic back pain

5/8/2015
Avelox Approved for Plague

Deadly bacteria could be used as bioterror agent

5/1/2015
Raplixa Approved to Control Surgical Bleeding

Spray-dried product promotes clotting when other methods are 'ineffective or impractical'

4/29/2015
Kybella Approved for Double Chin

Drug mimics body's own fat-destroying chemical

4/29/2015
First Generic Abilify Approved

For treatment of bipolar disorder or schizophrenia

4/16/2015
Generic Copaxone Approved for Multiple Sclerosis

Autoimmune disease affects central nervous system